ADVERTISEMENT

EU

EU Commission Confirms Olivér Várhelyi In Health Role

The EU’s health nominee may not be as controversial as the recent US one, but the candidate being grilled has proved the least popular of the commissioner nominations with MEPs

Olivér Várhelyi Confirmed In EU Commission’s Health Role

The EU’s health nominee may not be as controversial as the recent US one, but the candidate being grilled has proved the least popular of the commissioner nominations with MEPs

Is The EU Recreating A Different Monster Of A Regulatory Labyrinth?

Reflecting on 40 years of EU medtech regulation makes me realize how incredibly far we have come. But have we come full circle and replaced the frustrations of four decades ago with a different, but equally challenging, set of problems?

UK Kicks Off Seven-Week Pre-Market Regulatory Consultation

A short consultation has been launched by the UK MHRA on elements of devices regulation for Great Britain that have evolved since the first consultation on UKCA marking in 2021.

EU Persons Responsible For Medtech Regulatory Compliance: A Tough, Evolving Role

The EU’s PRRC role can differ substantially according to the circumstances at individual companies. But there is a need to further understand and shape PRRC's responsibilities so there is strong consistency across the board, PRRCs and associated stakeholders heard recently in Malaga.

EU Medtech Association Focuses On Innovation And Digital At 65th Anniversary

Medtech engineering association shares concerns over regulations, innovation and EU competitiveness with remainder of medtech industry.

Transnational Collaborative Health Tech Assessments Have Much To Offer

European cross-border HTA collaborations have much to learn from each other to keep drug prices from rising unfairly, say Nordic health technology assessment experts. Talks on HTA collaborations outside Europe are also underway.

Nordic HTA Body Tells Pharma Users: ‘Feel the Fear And Do It Anyway’

It is time for companies to take part in cross-country health technology assessments and stop only asking “what’s in it for me?”

Swiss Medtechs Eye Near-Term Regulatory Progress On EU And FDA Fronts

An agreement between the EU and Switzerland potentially opening the way for renewal of the MRA – enabling barrier-free cross-border medtech trade – could be concluded as early as December. More good news for Switzerland, relating to the acceptance of FDA-approved products into the country, could follow in Q1 2025.

European Commission Receives Contradictory Messages Over MDR Revision

The European Parliament wants the European Commission to revise the Medical Device Regulation within 100 days. But EU member state authorities warn of the consequences of rushing matters.